Skip to main content
. 2021 Nov 30;8:736272. doi: 10.3389/fmolb.2021.736272

FIGURE 1.

FIGURE 1

The overall design of the current study. Schematic illustration of the discovery procedure for the screening of potential diagnostic biomarkers for CRC in T2DM patients based on the DIA-MS method (A) and the validated procedure based on ELISA analysis (B).